Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ellagic Acid in Metabolic Syndrome
NCT04011618Phase 2Unknown
- Sponsor
- Universidad de Guadalajara
- Start
- Sep 2019
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Universidad de Guadalajara. Primary endpoints: Waist Circumference at 12 weeks, Blood Pressure at 12 weeks and 5 more. Status: unknown.
Beyond the preview
Go deeper on NCT04011618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04011618.